EP Bioptom
Precision diagnostic catheter
Electrophysiological diagnostic catheter
EP Bioptom is an innovative electrophysiological diagnostic catheter that enables endomyocardial biopsy while providing catheter positioning within a three-dimensional map of the heart.
Biopsy
Cardiac biopsy, also known as endomyocardial biopsy (EMB), is a procedure that facilitates the morphological, immunohistological, and structural examination of heart tissue. Myocardial biopsy is performed in various heart diseases, including sarcoidosis and cardiomyopathy. Biopsy is also indicated in cases of suspected cardiac cancer or when evaluating a transplanted heart.
Why is it worth it?
shorter and more effective treatments
a versatile solution combining two functions
precision of the treatment thanks to 3D mapping
Patent protection
EP Bioptom is equipped with biopsy forceps and a catheter featuring diagnostic rings, facilitating precise catheter positioning within the 3D electroanatomical map of the heart (EAM). Moreover, the EP Bioptom catheter can be linked to an irrigation system, enabling the flushing of its internal canal with a saline solution.
EP Bioptom market
The cardiac biopsy market is a dynamically evolving sector, valued at around USD 321 million in 2022, with a projected compound annual growth rate (CAGR) of 8%. Furthermore, recent guidelines from the European Society of Cardiology (ESC) reaffirm the crucial role of heart biopsy in both the diagnosis and treatment of cardiomyopathy. The cardiac biopsy market stands as a promising investment area, underscoring advancements in diagnostics and emphasizing the pivotal role this sector plays in shaping the future of medicine.
Project progress
In January 2023, a contract was signed with a German subcontractor to undertake research and development work specifically related to the design of the EP Bioptom catheter. The initial phase of the design work has been successfully completed, during which the company received prototypes of the device for internal testing purposes. The second phase of prototyping aims to prepare and produce catheters for preclinical tests.
* The aforementioned project signifies a product that has not yet received approval as a medical device from the relevant regulatory authority. Competitive advantages and other aspects of the aforementioned project will be substantiated thorough testing and research.
